Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia

NCT06534658 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06534658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06534658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Recruiting
Start date
July 30, 2020
Completion date
August 30, 2029
Enrollment
1,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, image